Threat... and opportunity

The coronavirus epidemic, Co­vid-2019 has, so far, claimed over 2,300 lives and infected over 75,000 persons. So far, nothing has stopped its spread. One positive outcome of the crisis may be a review of vaccine research and development processes, leading to much faster development and deployment of new vaccines. On average, it takes over 10 years for a new vaccine to move from the lab onto pharmacy shelves. This involves a process of preclinical development; three clinical phases; preregistration; registration; and launch. There are hopes that new technology, fast-tracked clinical t.....

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel
Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.